Pfizer Inc

Holdings as of Jun 30, 2026 · filed Aug 13, 2026

$170365906
Portfolio value
17
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Allogene Therapeutics Inc $46928245 27.55% Held
2 Celcuity Inc $29550417 17.35% -53754 -15.38%
3 Arvinas Inc $27662520 16.24% Held
4 Pyxis Oncology Inc $19480773 11.43% Held
5 Wave Life Sciences Ltd $10931250 6.42% Held
6 Biohaven Ltd $8004360 4.70% Held
7 Caribou Biosciences Inc $7879924 4.63% Held
8 Spero Therapeutics Inc $5338906 3.13% Held
9 Zentalis Pharmaceuticals Inc $3853489 2.26% Held
10 Oric Pharmaceuticals Inc $3553775 2.09% -5003440 -93.06%
11 Cardiff Oncology Inc $3014469 1.77% Held
12 Zura Bio Ltd $2882799 1.69% -2431181 -81.86%
13 Agomab Therapeutics Nv $1035750 0.61% NEW BUY
14 Bolt Biotherapeutics Inc $133832 0.08% Held
15 Nextcure Inc $72967 0.04% -113299 -71.87%
16 Ginkgo Bioworks Holdings Inc $30012 0.02% Held
17 Senseonics Hldgs Inc $12418 0.01% Held

Closed last quarter

Q32 Bio Inc An2 Therapeutics Inc

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.